| Obesity as a risk factor for Alzheimer's disease: weighing the evidence S Alford, D Patel, N Perakakis, CS Mantzoros Obesity Reviews 19 (2), 269-280, 2018 | 219 | 2018 |
| Pharmacotherapy for the management of obesity D Patel Metabolism 64 (11), 1376-1385, 2015 | 143 | 2015 |
| Safety and tolerability of new-generation anti-obesity medications: a narrative review DK Patel, FC Stanford Postgraduate medicine 130 (2), 173-182, 2018 | 135 | 2018 |
| Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology NA Sangave, TD Aungst, DK Patel Diabetes Spectrum 32 (4), 378-384, 2019 | 92 | 2019 |
| The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit DK Patel, J Strong Diabetes Therapy, 1-22, 2019 | 70 | 2019 |
| Evaluation of the use of a virtual patient on student competence and confidence in performing simulated clinic visits CA Taglieri, SJ Crosby, K Zimmerman, T Schneider, DK Patel American journal of pharmaceutical education 81 (5), 2017 | 62 | 2017 |
| Differentiating basal insulin preparations: understanding how they work explains why they are different AYY Cheng, DK Patel, TS Reid, K Wyne Advances in Therapy 36, 1018-1030, 2019 | 57 | 2019 |
| Comparison of long-term knowledge retention in lecture-based versus flipped team-based learning course delivery C Taglieri, D Schnee, LD Camiel, K Zaiken, A Mistry, S Nigro, G Tataronis, ... Currents in Pharmacy Teaching and Learning 9 (3), 391-397, 2017 | 41 | 2017 |
| Insulin degludec: a novel basal insulin analogue JD Goldman-Levine, DK Patel, DM Schnee Annals of Pharmacotherapy 47 (2), 269-277, 2013 | 28 | 2013 |
| EPA’s pleiotropic mechanisms of action: a narrative review JR Nelson, MJ Budoff, OR Wani, V Le, DK Patel, A Nelson, RL Nemiroff Postgraduate medicine 133 (6), 651-664, 2021 | 26 | 2021 |
| Students’ attitudes, academic performance and preferences for content delivery in a very large self-care course redesign LD Camiel, A Mistry, D Schnee, G Tataronis, C Taglieri, K Zaiken, D Patel, ... American journal of pharmaceutical education 80 (4), 2016 | 26 | 2016 |
| Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes M Hompesch, DK Patel, JR LaSalle, GB Bolli Postgraduate medicine 131 (2), 117-128, 2019 | 21 | 2019 |
| Patient initiation and maintenance of GLP-1 RAs for treatment of obesity D Patel, A Smith Expert Review of Clinical Pharmacology 14 (10), 1193-1204, 2021 | 20 | 2021 |
| Antidiabetic agents and cardiovascular outcomes in patients with heart diseases JWM Cheng, HA Badreldin, DK Patel, SH Bhatt Current medical research and opinion 33 (6), 985-992, 2017 | 19 | 2017 |
| The rise of biosimilars: How they got here and where they are going D Patel, C Gillis, J Naggar, A Mistry, CS Mantzoros Metabolism 75, 45-53, 2017 | 18 | 2017 |
| Appropriate titration of basal insulin in type 2 diabetes and the potential role of the pharmacist D Patel, C Triplitt, J Trujillo Advances in Therapy 36, 1031-1051, 2019 | 14 | 2019 |
| Deoxycholic Acid (ATX-101) for Reduction of Submental Fat KC Dunican, DK Patel Annals of Pharmacotherapy 50 (10), 855-861, 2016 | 12 | 2016 |
| Glycaemic and non‐glycaemic efficacy of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes D Patel Journal of Clinical Pharmacy and Therapeutics 45, 28-42, 2020 | 10 | 2020 |
| Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report DK Patel, N Bilkha, D Schnee Journal of Medical Case Reports 7, 1-4, 2013 | 10 | 2013 |
| Concentrated Insulins: A Review and Recommendations JD Gonzalvo, DK Patel, JL Olin Federal Practitioner 34 (Suppl 8), S38, 2017 | 7 | 2017 |
